We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protein Profiling Assays Diagnose Periprosthetic Joint Infection

By LabMedica International staff writers
Posted on 05 Oct 2011
Molecular markers found in the protein in synovial fluid may aid in the diagnosis of patients undergoing revision arthroplasty for septic or aseptic failure.

Proteomic analysis has the potential as highly sensitive diagnostic tool for periprosthetic joint infection (PJI) that occur during surgical reconstruction or replacement of a malformed or degenerated joint.

Doctors at the Thomas Jefferson University Hospital (Philadelphia, PA, USA) collected synovial fluid specimens from selected patients in the operating room at the time of revision surgery and before incision into the joint (arthrotomy). Samples were assayed to determine the concentration of inflammatory proteins according to MultiAnalyte profiling (MAP) protocols established by Rules-Based Medicine (RBM; Austin, TX, USA). The samples were shipped to RBM for Human Inflammation MAP analysis, which quantifies concentrations of 46 inflammatory proteins in fluid samples using a multiplex enzyme-linked immunosorbent assay (ELISA) protocol.

The scientists analyzed 74 synovial fluid samples: 31 infected and 43 uninfected, based on clinical and laboratory criteria. Proteomics analysis and receiver operating characteristic curve analyses were conducted on 46 inflammatory proteins for each sample. Of the 46 proteins, 5 including interleukin 6, interleukin 8, alpha (2)-macroglobulin, C-reactive protein, and vascular endothelial growth factor had an area under the curve greater than 0.90, indicating their importance in infected joints. Of the infected cases, purulence was identified intraoperatively in 22 cases, and an organism was isolated preoperatively or intraoperatively in 16 cases. The organisms isolated included primarily Staphylococcus and Streptococcus species.

The study demonstrated that inflammatory proteins can be detected in synovial fluid and their concentrations ascertained, and these varying concentrations align well with the presence or absence of PJI. The study was published in September 2011, in the Journal of Arthroplasty.

Related Links:
Thomas Jefferson University Hospital
Rules-Based Medicine




Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Vaginitis Test
Allplex Vaginitis Screening Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.